Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatic Stellate Cells | 2 | 2020 | 53 | 0.700 |
Why?
|
| Caveolin 1 | 2 | 2017 | 59 | 0.670 |
Why?
|
| Liver Cirrhosis | 2 | 2020 | 301 | 0.580 |
Why?
|
| Endothelial Cells | 2 | 2017 | 384 | 0.550 |
Why?
|
| Liver | 2 | 2017 | 1118 | 0.470 |
Why?
|
| Serum Response Factor | 1 | 2020 | 15 | 0.190 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 37 | 0.180 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 102 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2020 | 237 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 142 | 0.160 |
Why?
|
| Cysteine | 1 | 2018 | 112 | 0.160 |
Why?
|
| Glycation End Products, Advanced | 1 | 2018 | 125 | 0.160 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2017 | 3 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 567 | 0.140 |
Why?
|
| Life Style | 1 | 2018 | 338 | 0.140 |
Why?
|
| Glutathione | 1 | 2018 | 343 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2020 | 753 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 284 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 102 | 0.140 |
Why?
|
| Capillaries | 1 | 2016 | 105 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2016 | 205 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2018 | 718 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2016 | 382 | 0.120 |
Why?
|
| Rats | 2 | 2020 | 5300 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1533 | 0.080 |
Why?
|
| Animals | 4 | 2020 | 20877 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2020 | 1199 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2020 | 1692 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2020 | 49 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2020 | 324 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 523 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 110 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2018 | 62 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 99 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2020 | 483 | 0.040 |
Why?
|
| Humans | 4 | 2018 | 68525 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 630 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 2017 | 41 | 0.040 |
Why?
|
| Receptor, Endothelin B | 1 | 2017 | 34 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2017 | 163 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 493 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Cancer Survivors | 1 | 2018 | 145 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 332 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 799 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 951 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2017 | 122 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1027 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1849 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2550 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 981 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 2083 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 2688 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5719 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 8472 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7028 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 21119 | 0.010 |
Why?
|
| Female | 1 | 2018 | 38015 | 0.010 |
Why?
|
| Male | 1 | 2017 | 37281 | 0.010 |
Why?
|